시장보고서
상품코드
1376525

체외진단약(IVD)의 동향과 시장 최신 정보(2023년 11월)

In Vitro Diagnostic (IVD) Trends and Market Update: November 2023

발행일: | 리서치사: Kalorama Information | 페이지 정보: 영문 40 Pages | 배송안내 : 1-2일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

체외진단용 의약품(IVD) 검사는 일반 업무로 돌아오고 있으며, 계속해서 의료 행위의 원동력이 되고 있습니다. IVD 검사는 의사가 질병을 진단하는 것을 돕는 것으로부터 정밀의료와 같은 치료에 관한 귀중한 정보를 의사에게 제공하는 것으로 변화하고 있습니다. COVID-19 검사는 계속 감소하고 있으나, 2023년 총수입의 요인인 것에 변화는 없습니다.

시장에는 업계의 주목을 받는 성장 부문이 몇개 있습니다. POC, 차세대 시퀀싱(NGS), 암검사, 동반진단 기술 등입니다. 면역화학, 질량분석, 유전자 검사 및 분자진단도 시장의 관심이 높은 분야이며, IVD의 미래에 큰 부분을 차지할 것으로 예상됩니다.

세계의 체외진단약(IVD) 시장에 대해 조사했으며, 시장의 개요와 주요 각사의 시장 참여 동향과 새로운 기회 등을 제공하고 있습니다.

목차

제1장 세계의 IVD 시장 - 2023년 10월 최신 정보

  • IVD 시장의 수요와 성장
  • COVID-19 진단 시장
  • COVID-19가 시장 부문에 미치는 영향

제2장 제품 동향과 신개발

  • 엄선된 신제품 - 2023년 3분기 - 코어 IVD 제품 발매, 개발, 동향
  • 임상화학
  • 유세포분석
  • 면역측정법
  • 질량분석법
  • 분자
  • 맞춤형 의료
  • POC
  • 시퀀싱
  • 일부 COVID-19의 개발 - 2023년 3분기
  • 항원·항체
  • 분자

제3장 주요 IVD 시장 참여 기업의 결과

  • 엄선된 경쟁력 있는 리더의 최신 정보
  • 3분기 M&A 활동
  • Abbott Laboratories
  • Becton Dickinson and Co
  • bioMérieux SA
  • Danaher Corporation
  • Hologic, Inc.
  • QuidelOrtho Corporation
  • Roche Diagnostic
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific

제4장 새로운 기회

  • 다중 테스트
  • 차세대 시퀀싱
  • 인공지능의 향후 동향
  • 파괴적 테크놀러지
KSA 23.11.20

In vitro diagnostic (IVD) testing is getting back to regular business and continues to be a driving force in the practice of medicine. It has gone from helping the physician to diagnose illness to providing the physician with invaluable information on treatments such as precision medicine. COVID-19 testing continues to decline but is still a factor in total revenues for 2023. New products, changes in global health spending, regulatory changes in major markets and disease trends are among the factors that produce a constantly changing market picture but one that remains resilient.

“IVD Trends and Market Update: November 2023” by Kalorama Information is the most up-to-date resource on these and other key market trends. Diagnostic test products have never been more important. This report is an update of the market for in vitro diagnostics products from Kalorama's analysts to reflect the latest information as of Q3 2023 with a publication date of November 2023.

There are some growing segments in the market that have attracted industry attention. Among these are Point-of-Care, next-generation sequencing (NGS), cancer testing, and companion diagnostics technologies. Immunochemistry, mass spectrometry. Gene testing and molecular diagnostics are also segments of great market interest, anticipated to be a big part of the future of IVD.

Trends highlighted throughout Q3 2023 include:

  • Multiplex testing is proliferating
  • Continued interest in adopting AI technologies

Kalorama Information maintains its unwavering dedication to examining the IVD market and its dynamically evolving landscape. The company's excellence in market analysis is attributed to the extensive expertise of its authors and the market research firm's resolute commitment to providing the most precise and up-to-date data.

In “IVD Trends and Market Update: November 2023”, you'll discover out:

  • What's Driving Growth in the IVD Market in Q3 and the last half of 2023?
  • What Major Trends are Affecting the Market in Q3 and the last half of 2023?
  • How Has COVID-19 Impacted and Continued to Impact the Market in Q3 and the last half of 2023?
  • What Product Trends and New Developments Will Shape the IVD Market in the last half of 2023?

Table of Contents

Chapter 1: Worldwide IVD Market - October 2023 Update

  • IVD Market Demand and Growth
  • Figure 1-1: Q3 Segment Performance Commentary, 2023
    • Table 1-1: Global In Vitro Diagnostic Sales by Product Market, 2023 ($ million) (Clinical Chemistry; Immunoassays - non isotopic [Infectious disease, Other immunos, Blood bank screening, Drugs of Abuse, Diabetes HbA1c - lab]; Hematology - Core Lab; Microbiology [ID/AST]; Microbiology [molecular]; Microbiology - Mass Spectrometry; Coagulation [PT/INR]; Coagulation, molecular; Histology/cytology; HPV, molecular; Nucleic acid assays; Blood grouping/typing; Blood bank molecular - NAT Screens; Circulating tumor cells; POC, OTC diabetes; POC, OTC other; POC, professional/hospital; Mass Spectrometry; Other IVD)
    • Figure 1-2: IVD Segment Performance, Q1 2023 - Q4 2023e ($MN)
    • Figure 1-3: IVD Segment Performance (Clinical Chemistry, Coagulation, Hematology, Histology, Immunoassay, Microbiology, POC, Other), Total Market Value, 2023 ($MN) Estimated
  • COVID-19 Diagnostic Markets
    • Table 1-2: COVID-19 Product Sales, by Segment (Immunoassay [Antigen, Serology], Molecular, Rapid [POC Professional, POC At-Home]), 2023 ($ millions)
  • Effect of COVID-19 on Market Segments
    • Table 1-3: IVD Market (excluding and with COVID-19), 2023 ($ millions)
    • Figure 1-4: IVD Market Distribution, by Segment (COVID-19 Assays and Instruments, IVD Market excluding COVID-19 Assays and Instruments), 2023 (%)
    • Figure 1-5: IVD Market by COVID-19 and non-COVID Markets, Quarterly Performance, 2023 Estimated ($ millions)
    • Table 1-4: Global In Vitro Diagnostic Market, by Segment (Clinical Chemistry; Immunoassays - non isotopic [Infectious disease, Other immunos, Blood bank screening, Drugs of Abuse, Diabetes HbA1c - lab]; Hematology - Core Lab; Microbiology [ID/AST]; Microbiology [molecular]; Coagulation [PT/INR]; Histology/cytology; d-dimer; Nucleic acid assays; Blood grouping/typing; Blood bank molecular - NAT Screens; POC, OTC diabetes; POC, OTC other; POC, professional/hospital), YoY Growth 2022-2023 (%)
    • Figure 1-6: Global In Vitro Diagnostic Market, by Segment (Clinical Chemistry; Immunoassays - non isotopic [Infectious disease, Other immunos, Blood bank screening, Drugs of Abuse, Diabetes HbA1c - lab]; Hematology - Core Lab; Microbiology [ID/AST]; Microbiology [molecular]; Coagulation [PT/INR]; Histology/cytology; d-dimer; Nucleic acid assays; Blood grouping/typing; Blood bank molecular - NAT Screens; POC, OTC diabetes; POC, OTC other; POC, professional/hospital), YoY Growth 2022-2023 (%)

Chapter 2: Product Trends and New Developments

  • Selected New - Q3 2023 - Core IVD Product Launches, Developments and Trends
  • Clinical Chemistry
  • Flow Cytometry
  • Immunoassay
  • Mass Spectrometry
  • Molecular
  • Personalized Medicine
  • POC
  • Sequencing
  • Selected COVID-19 Developments - Q3 2023
    • Figure 2-1: COVID-19 Test Market, by Type (Antigen, Molecular, Serology, Rapid), Q1-Q4 2023 ($ millions)
  • Antigen/Antibody
  • Molecular

Chapter 3: Top IVD Market Participant Results

  • Selected Competitive Leader Updates
    • Figure 3-1: IVD Segment Growth, by Leading Competitors (Abbott Diagnostics, Becton Dickinson, bioMérieux, Danaher, Exact Sciences, QuidelOrtho, Roche Diagnostics, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific), Change in Sales, 2022-2023 (%)
    • Figure 3-2: Changes in Market Distribution for IVD Sales, 2020-2023 - Roche and Abbott Battle for #1 Spot
    • Figure 3-3: Comparison of Total Diagnostic Sales for Abbott vs Roche, 2020-2023 ($ millions)
  • Q3 M&A Activity
    • Table 3-1: Q3 2023 Merger and Acquisition Activity
  • Abbott Laboratories
    • Table 3-2: Abbott Corporate Summary
  • Becton Dickinson and Co
    • Table 3-3: Becton Dickinson Corporate Summary
  • bioMérieux SA
    • Table 3-4: bioMérieux Corporate Summary
  • Danaher Corporation
    • Table 3-5: Danaher Corporation Summary
  • Hologic, Inc.
    • Table 3-6: Hologic Corporate Summary
  • QuidelOrtho Corporation
    • Table 3-7: QuidelOrtho Corporate Summary
  • Roche Diagnostic
    • Table 3-8: Roche Diagnostic Corporate Summary
  • Siemens Healthineers
    • Table 3-9: Siemens Healthineers Corporate Summary
  • Sysmex Corporation
    • Table 3-10: Sysmex Corporate Summary
  • Thermo Fisher Scientific
    • Table 3-11: Thermo Fisher Scientific Corporate Summary

Chapter 4: New Opportunities

  • Multiplex Testing
  • Next-Generation Sequencing
  • Artificial Intelligence Future Trends
  • Disruptive Technologies
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제